Quantitative assessment of the compliance with once-daily sublingual immunotherapy in children (EASY Project: Evaluation of A novel SLIT formulation during a Year)

Pediatric Allergy and Immunology

Volumn 18, Issue 1, 2007, Pages 58-62

  Passalacqua, Giovanni ^a,b   Musarra, Antonino ^c   Pecora, Silvia ^a   Amoroso, Saverio ^d   Antonicelli, Leonardo ^e   Cadario, Gianni ^f   Gioacchino, Mario Di ^g   Lombardi, Carlo ^h   Ridolo, Erminia ⁱ   Sacerdoti, Guido ^j   Schiavino, Domenico ^k   Senna, Gianenrico ^l  

^a Pad Maragliano ^*  (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c National Healthcare System   (Italy)

^d Hospital of Palermo   (Italy)

^e OSPEDALI RIUNITI   (Italy)

^f MOLINETTE HOSPITAL   (Italy)

^g UNIVERSITY OF CHIETI   (Italy)

^h S Orsola FBF Hospital   (Italy)

ⁱ UNIVERSITY OF PARMA   (Italy)

^j SECOND UNIVERSITY OF NAPLES   (Italy)

^k FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^l Verona Hospital   (Italy)

more..

Author keywords

Children; Compliance; Real life; Respiratory allergy; Sublingual immunotherapy

Indexed keywords

ALLERGEN; SLITONE; UNCLASSIFIED DRUG;

ADOLESCENT; ALLERGIC ASTHMA; ARTICLE; CHILD; CONTROLLED STUDY; DATA BASE; FEMALE; HAND EDEMA; HEALTH ECONOMICS; HUMAN; IMMUNOTHERAPY; INTERVIEW; ITALY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RHINOCONJUNCTIVITIS; TELEPHONE;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ALLERGENS; ANIMALS; ASTHMA; CHILD; CHILD, PRESCHOOL; CONJUNCTIVITIS, ALLERGIC; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; MALE; OBSERVATION; PATIENT COMPLIANCE; POACEAE; PYROGLYPHIDAE; RHINITIS, ALLERGIC, PERENNIAL; SELF ADMINISTRATION;

EID: 33846938383     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2006.00471.x     Document Type: Article

References (26)

1. Committee on the Safety of Medicines. CSM update. Desensitizing vaccines. Br Med J 1986: 293: 948.
2. World Health Organization Position Paper. Allergen immunotherapy: therapeutical vaccines for allergic diseases. In: BOUSQUET J, LOCKEY R, MALLING HJ, eds. Allergy 1998: 53 (Suppl.): 1-33.
3. BOUSQUET J, VAN CAUWENBERGE P, eds. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001: 108 (5 Suppl.): S146-50.
4. Allergen immunotherapy: a practice parameter. American Academy of Allergy, Asthma and Immunology. American College of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 2003: 90(1 Suppl 1): 1-40.
5. DI RIENZO V, PAGANI A, PARMIANI S, PASSALACQUA G, CANONICA GW. Post-marketing surveillance study on the safety of sublingual immunotherapy in children. Allergy 1999: 54: 1110-3.
6. LOMBARDI C, GARGIONI S, MELCHIORRE A, et al. Safety of sublingual immunotherapy in adults: a post marketing surveillance study. Allergy 2001: 56: 889-92.
7. DI RIENZO V, MUSARRA A, SAMBUGARO R, et al. Post marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years. Clin Exp Allergy 2005: 35: 560-4.
8. FIOCCHI A, PAJNO G, LA GRUTTA S, et al. Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years. Ann Allergy Asthma Immunol 2005: 95: 254-8.
9. NELSON HS. Advances in upper airway disease and allergen immunotherapy. J Allergy Clin Immunol 2003: 111: S793-8.
10. HAYNES RB. Introduction. In: HAYNES RB, TAYLOR DW, SACKETT L, eds. Compliance in Healthcare. Baltimore, MD: John Hopkins University Press, 1979: 262-268.
11. OSTERBERG L, BLASHKE T. Adherence to medication. N Engl J Med 2005: 353: 487-97.
12. PASSALACQUA G, MUSARRA A, PECORA S, et al. Quantitative assessment of the compliance with a once-daily sublingual immunotherapy regimen in real life (EASY Project: Evaluation of A novel SLIT formulation during a Year). J Allergy Clin Immunol 2006: 117: 946-8.
13. Global Initiative for Asthma. Guidelines 2006. http://www.ginasthma.com (last accessed October 2006).
14. ADAMS CD, DREYER ML, DINAKAR C, PORTNOY JM. Pediatric asthma: a look at adherence from the patient and family perspective. Curr Allergy Asthma Rep 2004: 4: 425-32.
15. O'CONNOR SL, BENDER BG, GAVIN-DEVITT LA, WAMBOLDT MZ, MILGROM H. Measuring adherence with the Doser CT in children with asthma. J Asthma 2004: 41: 663-70.
16. BECKER AB. Challenges to treatment goals and outcomes in pediatric asthma. J Allergy Clin Immunol 2002: 109 (6 Suppl.): S533-8.
17. IQBAL S, RITSON S, PRINCE I, DENYER J, EVERARD ML. Drug delivery and adherence in young children. Pediatr Pulmonol 2004: 37: 311-7.
18. BENDER B, WAMBOLDT FS, O'CONNOR SL, et al. Measurement of children's asthma medication adherence by self report, mother report, canister weight, and Doser CT. Ann Allergy Asthma Immunol 2000; 85: 416-21.
19. CHOO PW, RAND CS, INUI TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999: 37: 846-57.
20. TINKELMAN D, SMITH F, COLE WQ Jr, SLIK HJ. Compliance with an allergen immunotherapy regimen. Ann Allergy Asthma Immunol 1995: 74: 241-6.
21. LOWER T, HENSY J, MANDIK L, JANOSKY J, FRIDAY GA Jr. Compliance with allergen immunotherapy. Ann Allergy 1993: 70: 480-2.
22. MAROGNA M, SPADOLINI I, MASSOLO A, CANONICA GW, PASSALACQUA G. Randomized controlled open study of SLIT for respiratory allergy in real life: clinical efficacy and more. Allergy 2004: 59: 1205-10.
23. LOMBARDI C, GANI F, LANDI M, et al. Quantitative assessment of the adherence to sublingual immunotherapy. J Allergy Clin Immunol 2004: 113: 1219-20.
24. PAJNO GB, VITA D, CAMINITI L et al. Children's compliance with allergen immunotherapy according to administration routes. J Allergy Clin Immunol 2005: 116: 1380-1.
25. CARTER ER, ANANTHAKRISHNAN M. Adherence to montelukast versus inhaled corticosteroids in children with asthma. Pediatr Pulmonol 2003: 36: 301-4.
26. SHERMAN J, PATEL P, HUTSON A, CHESROWN S, HENDELES L. Adherence to oral montelukast and inhaled fluticasone in children with persistent asthma. Pharmacotherapy 2001: 21: 1464-7.